Korro Bio (KRRO) Interest & Investment Income (2019 - 2026)
Korro Bio (KRRO) posted Interest & Investment Income of -$224000.0 for Q1 2026, down 7566.67% on a QoQ basis from $3000.0 in Q4 2025, and down 7366.67% year-over-year from $3082.6 in Q1 2025.
Korro Bio (KRRO) Interest & Investment Income (2019 - 2026) Analysis & Trends
Korro Bio's Interest & Investment Income history runs 8 years deep, the most recent figure standing at -$224000.0 for Q1 2026.
- Quarterly Interest & Investment Income fell 7366.67% year-over-year to -$224000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$247000.0 (down 236.46% YoY) and the FY2025 annual result came in at -$26000.0, down 114.13% from the prior year.
- Interest & Investment Income was -$224000.0 for Q1 2026 at Korro Bio, down from $3000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $593000.0 in Q3 2024 and bottomed at -$430000.0 in Q4 2024.
- A 5-year average of $127071.4 and a median of $34500.0 in 2024 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2022 — Interest & Investment Income surged 456.1% — and 2024, when it sank 8500.0%.
- Korro Bio's Interest & Investment Income stood at $456000.0 in 2022, then slumped by 101.1% to -$5000.0 in 2023, then sank by 8500.0% to -$430000.0 in 2024, then jumped by 100.7% to $3000.0 in 2025, then plunged by 7566.67% to -$224000.0 in 2026.
- Business Quant data shows KRRO's Interest & Investment Income at -$224000.0 in Q1 2026, $3000.0 in Q4 2025, and $48000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Korro Bio | 123.70 Mn | 9.73 Mn | - | -224,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -224,000.00 |
| Dec 31, 2025 | 3,000.00 |
| Sep 30, 2025 | 48,000.00 |
| Jun 30, 2025 | -74,000.00 |
| Mar 31, 2025 | -3,000.00 |
| Dec 31, 2024 | -430,000.00 |
| Sep 30, 2024 | 593,000.00 |
| Jun 30, 2024 | 21,000.00 |
| Dec 31, 2023 | -5,000.00 |
| Mar 31, 2023 | 523,000.00 |
| Dec 31, 2022 | 456,000.00 |
| Sep 30, 2022 | 351,000.00 |
| Jun 30, 2022 | 425,000.00 |
| Mar 31, 2022 | 95,000.00 |
| Dec 31, 2021 | 82,000.00 |
| Sep 30, 2021 | 172,000.00 |
| Jun 30, 2021 | 118,000.00 |
| Mar 31, 2021 | 25,000.00 |
| Dec 31, 2020 | 32,000.00 |
| Sep 30, 2020 | 74,000.00 |